A detailed history of Point72 (Difc) LTD transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 14,114 shares of CLDX stock, worth $397,167. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,114
Previous 6,998 101.69%
Holding current value
$397,167
Previous $259 Million 85.22%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.06 - $44.56 $228,138 - $317,088
7,116 Added 101.69%
14,114 $480 Million
Q2 2024

Aug 14, 2024

SELL
$32.76 - $42.56 $138,640 - $180,113
-4,232 Reduced 37.68%
6,998 $259 Million
Q1 2024

May 15, 2024

BUY
$35.22 - $51.88 $395,520 - $582,612
11,230 New
11,230 $471 Million

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.32B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.